C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/81 (2006.01) A61K 38/57 (2006.01) C12N 9/99 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2186111
The present invention is a therapeutic or prophylactic agent for viral diseases whose active ingredient is antileukoprotease (ALP). Formulations containing ALP as an active ingredient have particularly effective application against viral diseases, particularly viral diseases caused by viruses which are activated by tryptase Clara, i.e. viruses with envelope glycoproteins, which replicate by infection of the respiratory-tract, such as influenza virus, parainfluenza virus, RS virus, measles virus and mumps virus.
La présente invention concerne un remède ou un préventif contre les maladies virales, et dont le principe actif est une antileucoprotéase (ALP) qui est efficace notamment contre les maladies virales provoquées par des virus activables par la tryptase clara. Il s'agit notamment de maladies provoquées par des virus contenant des glycoprotéines adventitielles et favorisant la prolifération d'une infection des voies respiratoires, par exemple le virus grippal, le virus parainflunza, le virus respiratoire syncytial, le virus de la rougeole, ou le virus des oreillons.
Kido Hiroshi
Sekido Shozaburo
Tashiro Masato
Gowling Lafleur Henderson Llp
Mitsubishi-Tokyo Pharmaceuticals Inc.
LandOfFree
Novel remedy for respiratory-tract viral disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel remedy for respiratory-tract viral disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel remedy for respiratory-tract viral disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1485728